Tag: Trevi Therpaeutics
Cortexyme: Addressing Unmet Needs in the Alzheimer’s Market
The stocks of Cortexyme, Inc (NASDAQ: CRTX), a clinical stage biopharmaceutical company engaged in developing novel therapeutics for Alzheimer’ disease, surged by almost 70%...
We are looking for talented interns to learn and help investors find valuable companies.